Herbal Use Linked to Lower Autoantibodies in Dermatomyositis
Okay, here’s a breakdown of the provided text, focusing on the key details and potential implications. I’ll organize it for clarity:
Main Point:
The text discusses a study investigating the relationship between the use of immunostimulatory herbs and the onset/characteristics of dermatomyositis, an autoimmune disease. The study suggests that while some herbs may be associated with lower autoantibody rates, many, particularly spirulina, are linked to exacerbated disease onset due to increased inflammatory cytokine production.
Key Findings & Details:
* Herbs & Autoimmunity: Numerous studies are now linking immunostimulatory herbs to the worsening of autoimmune diseases.
* Spirulina as a Culprit: Spirulina is the most commonly associated herb with flaring autoimmune diseases, specifically dermatomyositis. It appears to increase inflammatory cytokine production.
* Study Cohort:
* 286 patients with dermatomyositis.
* Predominantly female (254/286).
* Average age of disease onset: 49 years.
* 13% (36 patients) used immunostimulatory herbs.
* Median time between frist herb use and dermatomyositis onset: 12 months (range 6-12 months).
* Herbs Investigated: alfalfa, ashwagandha, chlorella, echinacea, elderberry, spirulina, and tongkat ali.
* Spirulina Prevalence: spirulina was the most frequently used herb (61% of those using herbs – 22 out of 26).
* Data Source: University of Pennsylvania’s dermatomyositis database (patients provided informed consent).
* Outcomes Measured:
* Rates of myositis-associated autoantibodies (MAAs)
* Rates of myositis-specific autoantibodies (MSAs)
* Rates of antinuclear autoantibodies (ANAs)
* Disease activity (measured using CDASI-A scores at 3 months before onset and at first visit).
* initial Results: MSA, MAA, and ANA rates where all lower in the herbal intake group.
Important Notes/Context from the surrounding HTML:
* FDA Regulation: The text mentions the need for more regulation from the FDA regarding herbal supplements.
* External Link: There’s a link to an AJMC topic page on policy, suggesting a broader discussion about regulation.
* Figure: A figure is included showing herbal supplements linked to lower autoantibody rates in dermatomyositis, suggesting choice immune activation.
* Client-Side Rendering: The ssr="" client="load" attributes indicate that parts of the page are rendered on the client-side (in the browser) for performance reasons.
Potential Implications:
* Caution with Herbal Supplements: Individuals with autoimmune conditions (or those at risk) shoudl exercise extreme caution when considering immunostimulatory herbs.
* Spirulina as a Particular Concern: Spirulina appears to be a particularly problematic herb for those with or prone to dermatomyositis.
* Need for Further Research: More research is needed to fully understand the complex interactions between herbs, the immune system, and autoimmune disease development.
* Importance of Regulation: the text highlights the need for better regulation of herbal supplements to ensure safety and accurate labeling.
Let me know if you’d like me to elaborate on any specific aspect of this text or analyze it further!